CHIBA, Japan & SAN DIEGO--(BUSINESS WIRE)--Transparent Inc., a leader in 3D cell culture plate design and applications supported by comprehensive patent portfolio in biomaterial sciences, and Molecular Response Laboratories, (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics, today announced extension of their original validation studies and execution of key long term collaboration agreement.
